Characterization of two novel proabsorptive peptide YY analogs, BIM- 43073D and BIM-43004C

David A. Litvak, Hideaki Iseki, B. Mark Evers, George H. Greeley, Mark R. Hellmich, Kazuhiro Iwase, Ambikaipakan Balasubramaniam, Courtney M. Townsend

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


Effective clinical therapy to augment intestinal absorption of water and electrolytes does not exist; the gut hormone, peptide YY (PYY), is a potent proabsorptive agent in animal models. The purpose of our study was to evaluate the effects of two novel PYY analogs, BIM-43073D and BIM-43004C, on intestinal absorption. Dogs with ileal Thiry-Vella fistulae (TVF) were treated with either PYY, BIM-43073D, or BIM-43004C. Administration of BIM- 43073D significantly increased water and sodium absorption over baseline and maintained this level of increased absorption for a longer duration than an equimolar dose of PYY. Administration of BIM-43004C significantly increased sodium and water absorption over baseline at a level equal to that of PYY. The novel PYY analogs, BIM-43073D and BIM-43004C, are effective proabsorptive agents with BIM-43073D producing more sustained effects than PYY. These compounds may be clinically useful in the treatment of gut malabsorption in conditions such as cholera, Crohn's disease, and the short-bowel syndrome.

Original languageEnglish
Pages (from-to)643-648
Number of pages6
JournalDigestive Diseases and Sciences
Issue number3
StatePublished - 1999

Bibliographical note

Funding Information:
Manuscript receive d June 4, 1998; accepte d October 8, 1998. From the De partme nt of Surgery, The Unive rsity of Texas Medical Branch, Galve ston, Texa; asdntheUnive rsity of Cincinnati Medical Center, Cincinnati, Ohio. Daid vA. Litvak was a visiting scientist from the Universtiy California, Dais-Evast Bay Oakland, California. Presente d, in part, at the Association for Academic Surgery meeting(November6± 8,1997)inDallas,Texas. This work was funded by grants from the National Institutes of Health (PO1 DK36085, T32-DK07633, and GM47122) , and a grant from Biomeasure Inc. (Medford, Massachusetts). Address for reprint requests: Dr. Courtney M. Townsend, Jr., De partme nt of Surgery, The Unive rsity of TexaMsdical Beranch, 301 Unive rsity Boulevard, Galveston, Texa77s5550527-.


  • Intestinal absorption
  • PYY analog
  • Peptide YY
  • Proabsorptive agent

ASJC Scopus subject areas

  • Physiology
  • Gastroenterology


Dive into the research topics of 'Characterization of two novel proabsorptive peptide YY analogs, BIM- 43073D and BIM-43004C'. Together they form a unique fingerprint.

Cite this